Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months

Table 2

Information to identify the risk factors for the development of BRONJ [12].

Risk factors	Description
Diagnosis of malignant neoplasia	(i) Type of cancer; (ii) Presence of metastases and localization previous therapy (surgery, radiotherapy)
Drug administered	(i) Type; (ii) Total dosage; (iii) Recruitment; (iv) Timing of therapy
Other drugs	(i) Corticosteroids; (ii) Antiangiogenic
Oral history	(i) Traumas; (ii) Surgical procedures; (iii) Dental and gum infections; (iv) Diagnosis of periodontal disease; (v) Implantology; (vi) Prosthesis
Oral hygiene	(i) Daily home care; (ii) Annual frequency professional care; (iii) Motivation and information level